← Browse by Condition

Medical Condition

pancreatic adenocarcinoma

Total Trials

12

Recruiting Now

12

Trial Phases

Phase 2, Phase 1, Phase 3

NCT06789679 Phase 2

Albumin-Bound Paclitaxel and Gemcitabine With or Without S-1 as First-Line Treatment for Advanced Pancreatic Cancer

Cancer Institute and Hospital,...

Improving Pancreatic Cancer Care by the Use of Computational Science and Technology

NCT06896188 Phase 1

9-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With Advanced Pancreatic Adenocarcinoma (RiLEY)

NCT05624918 Phase 2

A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma

NCT07349537 Phase 1

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

Revolution Medicines, Inc.

Small Intestinal Bacterial Overgrowth (SIBO) in Pancreatic Adenocarcinoma (PDAC)

Cedars-Sinai Medical Center

NCT06789172 Phase 1

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

United States, Austr...

Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

M.D. Anderson Cancer Center

NCT05482516 Phase 3

Evaluating Novel Therapies in ctDNA Positive GI Cancers

Georgetown University

NCT05083247 Phase 2

Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma

Erasme University Hospital

NCT04361708 Phase 1

Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies

University of Chicago